DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea
· Delayed Price · Currency is KRW 19,220
+360 (1.91%)
Mar 10, 2026, 10:00 AM KST
DongKook Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 843,773 | 726,357 | 710,431 | 729,658 | 958,073 | 1,285,488 | Upgrade
|
| Market Cap Growth | 23.49% | 2.24% | -2.63% | -23.84% | -25.47% | 64.14% | Upgrade
|
| Enterprise Value | 899,585 | 792,360 | 751,610 | 743,265 | 932,778 | 1,201,020 | Upgrade
|
| Last Close Price | 18860.00 | 16330.33 | 15783.38 | 16031.86 | 20834.20 | 27731.01 | Upgrade
|
| PE Ratio | 13.88 | 11.95 | 15.19 | 13.79 | 19.03 | 22.99 | Upgrade
|
| Forward PE | 10.85 | 11.01 | 11.66 | 11.64 | 15.82 | 17.35 | Upgrade
|
| PS Ratio | 0.94 | 0.89 | 0.97 | 1.10 | 1.61 | 2.30 | Upgrade
|
| PB Ratio | 1.14 | 1.07 | 1.18 | 1.31 | 1.90 | 2.82 | Upgrade
|
| P/TBV Ratio | 1.38 | 1.27 | 1.33 | 1.48 | 2.14 | 3.18 | Upgrade
|
| P/FCF Ratio | 20.32 | 14.88 | 93.28 | - | - | 65.92 | Upgrade
|
| P/OCF Ratio | 11.13 | 9.55 | 17.00 | 17.84 | 21.46 | 21.75 | Upgrade
|
| EV/Sales Ratio | 1.01 | 0.98 | 1.03 | 1.12 | 1.57 | 2.15 | Upgrade
|
| EV/EBITDA Ratio | 7.54 | 7.32 | 8.54 | 8.02 | 11.58 | 12.29 | Upgrade
|
| EV/EBIT Ratio | 10.21 | 9.92 | 11.24 | 10.11 | 14.76 | 14.54 | Upgrade
|
| EV/FCF Ratio | 21.66 | 16.24 | 98.69 | - | - | 61.59 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.12 | 0.13 | 0.12 | 0.19 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.61 | 0.74 | 0.87 | 0.72 | 1.22 | 0.70 | Upgrade
|
| Debt / FCF Ratio | 1.76 | 1.65 | 10.07 | - | - | 3.51 | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.01 | -0.03 | -0.07 | -0.14 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.35 | -0.09 | -0.20 | -0.44 | -0.89 | -1.10 | Upgrade
|
| Net Debt / FCF Ratio | -1.03 | -0.21 | -2.29 | 5.82 | 11.34 | -5.53 | Upgrade
|
| Asset Turnover | 0.91 | 0.91 | 0.91 | 0.87 | 0.84 | 0.93 | Upgrade
|
| Inventory Turnover | 2.40 | 2.45 | 2.48 | 2.53 | 2.69 | 3.17 | Upgrade
|
| Quick Ratio | 1.34 | 1.26 | 1.34 | 1.49 | 1.40 | 2.15 | Upgrade
|
| Current Ratio | 2.08 | 2.02 | 2.06 | 2.22 | 1.91 | 2.75 | Upgrade
|
| Return on Equity (ROE) | 9.51% | 9.72% | 8.42% | 10.33% | 11.03% | 13.76% | Upgrade
|
| Return on Assets (ROA) | 5.72% | 5.57% | 5.20% | 6.05% | 5.59% | 8.55% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.66% | 9.36% | 9.75% | 12.39% | 12.30% | 18.70% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.60% | 11.10% | 10.50% | 12.40% | 11.90% | 15.90% | Upgrade
|
| Earnings Yield | 7.17% | 8.43% | 6.64% | 7.25% | 5.25% | 4.35% | Upgrade
|
| FCF Yield | 4.92% | 6.72% | 1.07% | -0.96% | -0.66% | 1.52% | Upgrade
|
| Dividend Yield | 1.01% | 1.23% | - | - | - | - | Upgrade
|
| Payout Ratio | 15.20% | 13.58% | 17.07% | 15.22% | 15.99% | 12.79% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -0.02% | -0.01% | - | - | Upgrade
|
| Total Shareholder Return | 1.00% | 1.21% | -0.02% | -0.01% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.